UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy

Biochemical pharmacology, 2012-04, Vol.83 (7), p.932-940

2012

Volltextzugriff (PDF)

Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications

Diabetes (New York, N.Y.), 2005-01, Vol.54 (1), p.234-242

2005

Volltextzugriff (PDF)

Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC–MS/MS method

Toxicology (Amsterdam), 2006-09, Vol.226 (2), p.208-217

2006

Volltextzugriff (PDF)

High glucose‐induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32

Journal of neurochemistry, 2006-07, Vol.98 (2), p.446-458

2006

Volltextzugriff (PDF)

Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs

European journal of drug metabolism and pharmacokinetics, 2013-06, Vol.38 (2), p.87-96

2013

Volltextzugriff (PDF)

Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells

Biochemical and biophysical research communications, 2004-02, Vol.314 (2), p.370-376

2004

Volltextzugriff (PDF)

Differential Effects of High Glucose and Methylglyoxal on Viability and Polyol Metabolism in Immortalized Adult Mouse Schwann Cells

The Open diabetes journal, 2008-12, Vol.1 (1), p.1-11

2008

Volltextzugriff (PDF)

Effects of N-[2-(1-Azabicyclo[3, 3, 0]octan-5-yl)ethyl]2-nitroaniline Fumarate (SK-946), a Novel Cognition Activator, on Learning and Memory in Rodent Models

Biological and Pharmaceutical Bulletin, 1998/07/15, Vol.21(7), pp.698-703

1998

Volltextzugriff (PDF)

Caracterlzatlon of the Neurochemical Effects N-(2-(l-azabicyclo(3,3,0)octan-5-yl)ethyl)2-nitroaniline fumarate (SK-946) as a Cognition Activator

Biological & pharmaceutical bulletin, 1998, Vol.21 (7), p.704-709

1998

Volltextzugriff (PDF)

Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes

Biochemical and biophysical research communications, 2002-11, Vol.299 (2), p.183-188

2002

Volltextzugriff (PDF)

Characterization of the Neurochemical Effects of N-[2-(1-azabicyclo[3, 3, 0]octan-5-yl)ethyl]2-nitroaniline fumarate (SK-946) as a Cognition Activator

Biological and Pharmaceutical Bulletin, 1998/07/15, Vol.21(7), pp.704-709

1998

Volltextzugriff (PDF)

Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo

Scientific reports, 2020-03, Vol.10 (1), p.5133-5133, Article 5133

2020

Volltextzugriff (PDF)

A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study

The American journal of gastroenterology, 2022-10, Vol.117 (10), p.1605-1613

2022

Volltextzugriff (PDF)

Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study

The American journal of gastroenterology, 2024-08, Vol.119 (8), p.1706-1706

2024

Volltextzugriff (PDF)

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study

Hepatology international, 2022-10, Vol.16 (5), p.1150-1160

2022

Volltextzugriff (PDF)

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

European journal of cancer (1990), 2023-08, Vol.189, p.112933-112933, Article 112933

2023

Volltextzugriff (PDF)

Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study

Journal of gastroenterology, 2016-02, Vol.51 (2), p.144-152

2016

Volltextzugriff (PDF)

Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.325-334

2023

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

European journal of cancer (1990), 2023-02, Vol.180, p.9-20

2023

Volltextzugriff (PDF)

Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice

Hepatology research, 2022-09, Vol.52 (9), p.773-783

2022

Volltextzugriff (PDF)

Development and validation of a modified albumin–bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab

Hepatology international, 2023-02, Vol.17 (1), p.86-96

2023

Volltextzugriff (PDF)

Effect of piceatannol on circadian Per2 expression in vitro and in vivo

Journal of functional foods, 2019-05, Vol.56, p.49-56

2019

Volltextzugriff (PDF)

Comparison of surgical outcomes between iStent inject W implantation and microhook ab interno trabeculotomy in combination with phacoemulsification in primary open-angle glaucoma patients

Frontiers in medicine, 2023-09, Vol.10, p.1266532-1266532

2023

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(75)

Sprache

Englisch
(74)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(61)
Hepatocellular Carcinoma
(35)
Liver Cancer
(32)
Humans
(31)
Oncology
(28)
Bevacizumab
(27)
Atezolizumab Plus Bevacizumab
(24)
Gastroenterology & Hepatology
(21)
Patients
(20)
Prognosis
(18)
Survival
(18)
Medical Prognosis
(17)
Medicine
(16)
Carcinoma, Hepatocellular - Drug Therapy
(15)
Liver Neoplasms - Drug Therapy
(15)
Medicine & Public Health
(15)
Retrospective Studies
(14)
Bilirubin
(12)
Female
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy

Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications

Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC–MS/MS method

High glucose‐induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32

Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs

Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells

Differential Effects of High Glucose and Methylglyoxal on Viability and Polyol Metabolism in Immortalized Adult Mouse Schwann Cells

Effects of N-[2-(1-Azabicyclo[3, 3, 0]octan-5-yl)ethyl]2-nitroaniline Fumarate (SK-946), a Novel Cognition Activator, on Learning and Memory in Rodent Models

Caracterlzatlon of the Neurochemical Effects N-(2-(l-azabicyclo(3,3,0)octan-5-yl)ethyl)2-nitroaniline fumarate (SK-946) as a Cognition Activator

Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes

Characterization of the Neurochemical Effects of N-[2-(1-azabicyclo[3, 3, 0]octan-5-yl)ethyl]2-nitroaniline fumarate (SK-946) as a Cognition Activator

Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo

A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study

Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study

Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice

Development and validation of a modified albumin–bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab

Effect of piceatannol on circadian Per2 expression in vitro and in vivo

Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis

Comparison of surgical outcomes between iStent inject W implantation and microhook ab interno trabeculotomy in combination with phacoemulsification in primary open-angle glaucoma patients

Suchergebnisse filtern